Analgesics - Sudan

  • Sudan
  • In Sudan, the revenue generated in the Analgesics market in 2024 amounts to US$20.48m.
  • It is projected to experience an annual growth rate of 4.95% (CAGR 2024-2029).
  • In comparison to other countries, the in the United States generates the highest revenue in this market, amounting to US$7,243.00m in 2024.
  • When considering the total population, the per person revenue in Sudan is US$0.41 in 2024.
  • Despite the economic challenges faced in Sudan, the demand for analgesics in the OTC pharmaceuticals market remains steady due to the prevalent health issues and limited access to healthcare facilities.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Sudan has seen significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences:
Customers in Sudan are increasingly seeking out analgesics to manage pain and discomfort. This is due to a variety of factors, including a growing awareness of the importance of self-care and the availability of a wider range of analgesic products in the market. Additionally, the rising prevalence of chronic diseases and conditions that cause pain, such as arthritis and migraines, has also contributed to the increased demand for analgesics.

Trends in the market:
One of the key trends in the analgesics market in Sudan is the growing popularity of over-the-counter (OTC) analgesics. Customers are increasingly opting for OTC analgesics due to their convenience and accessibility. OTC analgesics are readily available in pharmacies and supermarkets, allowing customers to easily purchase them without a prescription. This trend is expected to continue as customers become more empowered to manage their own healthcare and seek out self-care options. Another trend in the market is the increasing demand for natural and herbal analgesics. Customers are becoming more conscious of the potential side effects of traditional analgesics and are seeking out alternative options. Natural and herbal analgesics, which are perceived to be safer and more gentle on the body, are gaining popularity among customers in Sudan. This trend is in line with the global shift towards natural and organic products in the healthcare industry.

Local special circumstances:
Sudan has a high prevalence of infectious diseases, such as malaria and dengue fever, which can cause fever and pain. This has led to a higher demand for analgesics in the country, as patients seek relief from the symptoms of these diseases. Additionally, Sudan has a relatively young population, with a large proportion of the population under the age of 30. This younger demographic is more likely to engage in physical activities and sports, leading to a higher incidence of injuries and the need for pain management.

Underlying macroeconomic factors:
The growing economy in Sudan has contributed to the development of the analgesics market. As the economy improves, customers have more disposable income to spend on healthcare products, including analgesics. Additionally, the increasing urbanization in Sudan has led to a higher demand for analgesics, as urban dwellers are more likely to be exposed to factors that cause pain, such as pollution and stress. In conclusion, the Analgesics market in Sudan is experiencing growth due to changing customer preferences, including the increasing demand for OTC analgesics and natural/herbal options. Local special circumstances, such as the high prevalence of infectious diseases and the young demographic, also contribute to the development of the market. The underlying macroeconomic factors, such as the growing economy and urbanization, further support the growth of the analgesics market in Sudan.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)